A Letter From The Uscom CEO: July 2018, page-5

I draw your attention to the following extract from the post posted by salston :

Thank you to our shareholders and supporters over the FY 2018 year, none of this happens without the support of investors. The acquisition and integration of two global companies and the development and launch of seven new products across four continents has been an ambitious project. This has taken longer and cost more than expected, but the opportunities it has created are much greater than was ever predicted. This future value is yet to be recognised by the broader market.

What are our strategies for 2019?

For FY 2019 we will continue to invest in fundamentals, progress the launch of our new products globally, expand our international operations and grow our sales and marketing organisation and drive global revenues. Much of our spend and activities for the year were non recurring and not directly revenue generating, and we look forward to smooth operations and strong growth in sales from our healthy pipelines in the year ahead as global markets settle. China will remain our single most important focus as we develop the opportunities created by our new China investment and organisation. We intend to position Uscom China as a reliable growth conduit into the fastest growing medical device market in the world and drive our revenue growth.

FY 2019 will be an exciting year for Uscom as we will build upon our growing foundations and progress towards our goal of making Uscom a billion dollar company.

Thanks for a great year and looking forward to an even better 2019.

Rob
Uscom, CEO